Bioxytran, Inc.
BIXT
$0.07
$0.002.21%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.96% | 105.35% | -141.50% | 51.11% | 67.58% |
| Total Depreciation and Amortization | 180.00% | 66.67% | -5.00% | -23.68% | -16.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -510.00% | -498.95% | 84.64% | 20.92% | -95.02% |
| Change in Net Operating Assets | 13.31% | -70.27% | 22,143.75% | -91.98% | -45.61% |
| Cash from Operations | 43.54% | -14.79% | -52.65% | 147.62% | 78.55% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 84.26% | -2,271.43% | 100.00% | -83.33% | 14.96% |
| Cash from Investing | 84.26% | -2,271.43% | 100.00% | -83.33% | 14.96% |
| Total Debt Issued | -60.95% | 836.63% | 67.34% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -48.34% | 29.41% | 67.34% | -236.67% | -72.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.23% | -134.29% | 95.03% | 45.57% | -39.60% |